{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:12:10Z","timestamp":1787782330039,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijantimicag.2023.106809","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T23:04:20Z","timestamp":1680735860000},"page":"106809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC \u03b2-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study"],"prefix":"10.1016","volume":"62","author":[{"given":"Alexis","family":"Maillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-8934","authenticated-orcid":false,"given":"Tristan","family":"Delory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Chaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9lia","family":"Escaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-1423","authenticated-orcid":false,"given":"Adrien","family":"Contejean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bercot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"El Alaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Tankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Poupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Cuzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Lafaurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Surgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-8966","authenticated-orcid":false,"given":"Adrien","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Paccoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bleibtreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106809_bib0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s15010-019-01291-9","article-title":"AmpC \u03b2-lactamase-producing Enterobacterales: what a clinician should know","volume":"47","author":"Meini","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0002","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ajic.2006.05.238","article-title":"Resistance in Gram-negative bacteria: Enterobacteriaceae","volume":"34","author":"Paterson","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0003","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"Antibacterial Resistance Leadership Group. A primer on AmpC \u03b2-lactamases: necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","article-title":"Interplay between \u03b2-lactamases and new \u03b2-lactamase inhibitors","volume":"17","author":"Bush","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/cid\/cit395","article-title":"The use of cefepime for treating AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"57","author":"Tamma","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0006","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/cid\/ciu182","article-title":"Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia","volume":"58","author":"Siedner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkv346","article-title":"Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis","volume":"71","author":"Harris","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.015","article-title":"Infections caused by naturally AmpC-producing Enterobacteriaceae: can we use third-generation cephalosporins? A narrative review","volume":"55","author":"Mizrahi","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0009","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC \u03b2-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/hygiene1020007","article-title":"Clinical failure and emergence of resistance during third generation cephalosporin therapy for Enterobacter spp. infection: is the risk overestimated? A prospective multicentric study","volume":"1","author":"Pilmis","year":"2021","journal-title":"Hygiene"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0011","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.01083-07","article-title":"Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC \u03b2-lactamase: implications for antibiotic use","volume":"52","author":"Choi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0012","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcrc.2019.11.005","article-title":"Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacterales in critically ill patients with hospital or ventilator-acquired pneumonia","volume":"56","author":"Carri\u00e9","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0014","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF00577747","article-title":"Development of resistance by Enterobacter cloacae during therapy of pulmonary infections in intensive care patients","volume":"72","author":"F\u00fcssle","year":"1994","journal-title":"Clin Investig"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13613-022-01079-5","article-title":"Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with \u03b2-lactams: a prospective multicenter study","volume":"12","author":"Mounier","year":"2022","journal-title":"Ann Intens Care"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0016","doi-asserted-by":"crossref","first-page":"ofab387","DOI":"10.1093\/ofid\/ofab387","volume":"8","author":"Stewart","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/antibiotics9050254","article-title":"Multicenter, observational cohort study evaluating third-generation cephalosporin therapy for bloodstream infections secondary to Enterobacter, Serratia, and Citrobacter species","volume":"9","author":"Derrick","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0018","doi-asserted-by":"crossref","first-page":"e00276","DOI":"10.1128\/AAC.00276-17","article-title":"Piperacillin-tazobactam versus other antibacterial agents for treatment of bloodstream infections due to AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"61","author":"Cheng","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.medmal.2010.10.001","article-title":"Antibioth\u00e9rapie par voie g\u00e9n\u00e9rale dans les infections respiratoires basses de l'adulte. Pneumonie aigu\u00eb communautaire. Exacerbations de bronchopneumopathie chronique obstructive","volume":"41","author":"Chidiac","year":"2011","journal-title":"M\u00e9d Malad Infect"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.anrea.2018.07.003","article-title":"Pneumonies associ\u00e9es aux soins de r\u00e9animation","volume":"4","author":"Leone","year":"2018","journal-title":"Anesth R\u00e9anim"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0021","unstructured":"Comit\u00e9 de l'Antibiograme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. n.d. Available at: https:\/\/www.sfm-microbiologie.org\/boutique\/comite-de-lantibiograme-de-la-sfm-casfm\/[accessed 18 January 2023]."},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0022","unstructured":"EUCAST: Resistance mechanisms. n.d. Available at: https:\/\/www.eucast.org\/resistance_mechanisms\/[accessed 17 April 2021]."},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0023","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0024","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0025","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.45.9.2628-2630.2001","article-title":"Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp","volume":"45","author":"Kaye","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.105860","article-title":"Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs non-carbapenems","volume":"55","author":"Tan","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-017-0334-x","article-title":"Piperacillin\u2013tazobactam as alternative to carbapenems for ICU patients","volume":"7","author":"Pilmis","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0028","doi-asserted-by":"crossref","first-page":"ofad034","DOI":"10.1093\/ofid\/ofad034","article-title":"High dose cefepime versus carbapenems for bacteremia caused by Enterobacterales with moderate to high risk of clinically significant AmpC \u03b2-lactamase production","volume":"10","author":"Kunz Coyne","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106809_bib0029","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","volume":"47","year":"2021","journal-title":"Intensive Care Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:44:37Z","timestamp":1760377477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0924857923000882"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106809","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC \u03b2-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106809"}}